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A B S T R A C T
The liver is the largest, important organ and the site for essential biochemical reactions in
the human body. It has the function to detoxify toxic substances and synthesize useful
biomolecules. Therefore, damage to the liver leads to grave consequences. This damage re-
sulted from chronic alcoholic abuse, viral hepatitis or inheritedmetabolic disease. Liver damage
is associated with cellular necrosis, fibrosis, and increase in tissue lipid peroxidation and
depletion in tissue glutathione level. Most of the hepatotoxic chemicals damage liver cells
mainly by inducing lipid peroxidation and other oxidative damages in the liver. Natural an-
tioxidants are found in many compounds classified as secondary plant metabolites, e.g.
polyphenols (phenolic acids and flavonoids) and terpenoids (carotenoids), and the con-
sumption of foods that contain these compounds in large quantities seems to play an
important role in prophylaxis against many diseases. Herbal medicines derived from plant
extracts are being increasingly utilized to treat a wide variety of clinical disease. More at-
tention has been paid to the protective effects of natural antioxidants against drug induced
toxicities especially whenever free radical generation is involved. Popularity of herbal rem-
edies is increasing and at least one quarter of patients with liver disease use botanicals.
TheWorld Health Organization (WHO) estimates that 80 percent of the population of some
Asian and African countries presently use herbal medicine for some aspect of primary health
care. Some medicinal herbs have proven hepatoprotective potential. Silybum marianum (milk
thistle) has been used to treat liver diseases since the 16th century. Its major constituents
are the flavonoids silibinin, silydianin, silychristin, and isosilibinin, of which silibinin is the
biologically most active compound and used for standardization of pharmaceutical products.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
The liver is one of the largest organs in the human body and
the chief site for intensemetabolism and excretion (Ahsan et al.,
2009). It plays a major role in detoxification and excretion of
many endogenous and exogenous compounds; any injury to
it or impairment of its functions may lead to many implica-
tions on one’s health (Subramaniam et al., 2015). Hepatic
damage is associated with distortion of these metabolic
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functions. Liver damage is associated with cellular necrosis,
increase in tissue lipid peroxidation and depletion of reduced
glutathione levels. In addition, serum levels of many biochemi-
cal markers like transaminases, alkaline phosphatase, bilirubin,
triglycerides and cholesterol are elevated in liver disease
(Subramaniam et al., 2015). Liver diseases pose a serious chal-
lenge to international public health (Ahsan et al., 2009).
The liver plays a central role in transforming and clearing
chemicals and is susceptible to the toxicity from these agents.
Certain medicinal agents, when taken in overdoses and some-
times even when introduced within therapeutic ranges, may
injure the organ. Chemicals that cause liver injury are called
hepatotoxins (Friedman et al., 2003).
Hepatotoxicity is one of the main reasons behind with-
drawal of a drug from the market. Fifty percent of all acute liver
failures and 5% of all hospital admissions are associated with
drug-induced hepatotoxicity (Dey et al., 2013).
A number of plants have been shown to possess
hepatoprotective property by improving antioxidant status.
Thus, the efficacy of the drug would be preventive and passive
for defending against damages. Traditional medicines are ef-
fective in certain disorders and are based on experience in the
use of plant products in amelioration of common diseases.
Several Indian medicinal plants have in recent times been ex-
plored and the hepatoprotective effects of these plants have
been established (Kumar et al., 2009; Abdel-Salam et al., 20141).
Plant drugs are known to play a major role in the manage-
ment of liver diseases.There are many plants and their extracts
that have been shown to possess hepatoprotective activities
(Girish and Pradhan, 2012).
Treatment options for common liver diseases are limited,
and therapy with modern medicine may lack in efficacy. The
effectiveness of treatments such as those using corticoste-
roids and interferons is inconsistent, carries the risk of adverse
events, and is often too costly (Stickel and Schuppan, 2007).
So, there is a need for effective therapeutic agents with a low
incidence of side effects. The natural antioxidants, more re-
cently, have attracted considerable attention of users and
researchers largely on account of adverse toxicological reports
on some synthetic antioxidants and growing awareness among
consumers (Ramalakshmi et al., 2007). In fact, a single plant
may have diversity of phytochemicals ranging from bitter com-
pounds that stimulate digestive system, phenolic compounds
for antioxidant and many other pharmacological properties,
including antibacterial and antifungal, tannins that work as
natural antibiotics, diuretic substances, and alkaloids. (Miguel,
2010).
2. The liver
The liver is the largest solid organ in the body, weighing about
1.5 kg in an adult. It lies in the right upper quadrant of the
abdomen completely protected by the thoracic rib cage (Fig. 1).
The liver is connected to two large blood vessels, one called
hepatic artery and the other called the portal vein.The hepatic
artery carries blood from the aorta whereas the portal vein
carries blood containing digested food from the small intes-
tine. The basic functional unit of the liver is the liver lobule;
the human liver contains 50,000 to 100,000 individual lobules
(Adi and Alturkmani, 2013).
2.1. Hepatic physiology
The liver is the center of metabolic homeostasis (Adi and
Alturkmani, 2013; Sherwood, 1997). It serves as:
1. Vascular functions: for storage and filtration of blood.
a. The liver can store 200–400 ml of blood in liver sinu-
soids (useful in hemorrhage).
1 Underline (Abdel-Salam et al., 2014) means that this is Egyp-
tian research.
Fig. 1 – The liver (Polaxa, 2015).
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b. Kupffer cells (highly phagocytic) can remove 90% of bac-
teria in the portal venous blood.
c. Hepatocytes synthesize plasma proteins.
2. Metabolic functions: the liver cells have a very high meta-
bolic rate.
a. Carbohydrate metabolism: the liver act as a glucostat
under the effect of hormones (glycogenesis, glycoge-
nolysis, gluconeogenesis).
– Processing nutrients absorbed from digestive tract.The
liver converts glucose into glycogen, its storage form.
This glycogen can then be transformed back into
glucose if the body needs energy (Guyton and Hall,
2006).
b. Protein metabolism: deamination of amino acids, for-
mation of urea, synthesis of 90% of plasma proteins and
all non-essential amino acids.
– Synthesizing plasma proteins, including those neces-
sary for blood clotting. Most of the 12 clotting factors
are plasma proteins produced by the liver. If the liver
is damaged or diseased, it can take longer for the body
to form clots. Other plasma proteins produced by the
liver include albumin which binds many water-
insoluble substances and contributes to osmotic
pressure, fibrinogen which is the key to the clotting
process, and certain globulins which transport sub-
stances such as cholesterol and iron.
– Producing immune factors and removing bacteria,
helping the body fight infection.The phagocytes in the
liver produce acute-phase proteins in response to mi-
crobes. These proteins are associated with the
inflammation process, tissue repair, and immune cell
activities (Reichen, 1999).
c. Fat metabolism: oxidation of fatty acids, formation of li-
poproteins, cholesterol and phospholipids.
– The fatty acids produced by the digestion of lipids are
used to synthesize cholesterol and other substances.
The liver also has the ability to convert certain amino
acids into others (Guyton and Hall, 2006).
d. Storage of vitamins: (A, K, B12, and D) and iron
– Storing certain vitamins,minerals, and sugars.The liver
stores enough glucose in the form of glycogen to
provide about a day’s worth of energy. The liver also
stores fats, iron, copper, and many vitamins includ-
ing vitamins A, D, K, and B12 (Adi and Alturkmani, 2013;
Sherwood, 1997).
e. Detoxification: or excretion of drugs, hormones and other
substances.
– Removing and excreting body wastes and hormones
as well as drugs and other foreign substances. These
substances have entered the blood supply either
through production by metabolism within the body or
from the outside in the form of drugs or other foreign
compounds. Enzymes in the liver alter some toxins so
they can be more easily excreted in urine.
– Excretion of bilirubin. Bilirubin is one of the few waste
products excreted in the bile. Macrophages in the liver
remove worn out red blood cells from the blood. Bili-
rubin then results from the breakdown of the
hemoglobin in the red blood cells and is excreted into
the bile by hepatocytes. Jaundice results when biliru-
bin cannot be removed from the blood quickly enough
due to gallstones, liver disease, or the excessive break-
down of red blood cells (Adi and Alturkmani, 2013;
Sherwood, 1997).
3. Secretory and excretory function: formation of bile.
– Producing bile to aid in digestion. Bile salts aid in fat di-
gestion and absorption. Bile is continuously secreted by
the liver and stored in the gallbladder until a meal, when
bile enters the beginning of the small intestine. Bile pro-
duction ranges from 250 ml to 1 l per day depending on
the amount of food eaten (Guyton and Hall, 2006).
2.2. Physiological changes due to hepatotoxicity
The liver plays a central role in transforming and clearing
chemicals and is susceptible to the toxicity from these agents.
More than 900 drugs have been implicated in causing liver injury
(Friedman et al., 2003) and it is the most common reason for
a drug to be withdrawn from the market. Hepatotoxicity and
drug-induced liver injury also account for a substantial number
of compound failures, highlighting the need for drug screen-
ing assays, such as stem cell-derived hepatocyte-like cells, that
are capable of detecting toxicity early in the drug develop-
ment process (Greenhough et al., 2010). Chemicals often cause
subclinical injury to the liver, which manifests only as abnor-
mal liver enzyme tests. Drug-induced liver injury is responsible
for 5% of all hospital admissions and 50% of all acute liver fail-
ures (Nally and Peter, 2006; Ostapowicz et al., 2002).
2.3. Drug metabolism in the liver
The human body identifies almost all drugs as foreign sub-
stances (i.e. xenobiotics) and subjects them to various chemical
processes (i.e. metabolism) to make them suitable for elimi-
nation. This involves chemical transformations to reduce fat
solubility and to change biological activity. Although almost
all tissues in the body have some ability to metabolize chemi-
cals, smooth endoplasmic reticulum in the liver is the principal
“metabolic clearing house” for both endogenous chemicals (e.g.,
cholesterol, steroid hormones, fatty acids, proteins) and ex-
ogenous substances (e.g., drugs, alcohol) (Blumenthal et al.,
2006).
Drug metabolism is usually divided into two phases: phase
1 and phase 2. Phase 1 reaction is thought to prepare a drug
for phase 2. However, many compounds can be metabolized
by phase 2 directly. Phase 1 reaction involves oxidation, re-
duction, hydrolysis, hydration and many other rare chemical
reactions.These processes tend to increase water solubility of
the drug and can generate metabolites that are more chemi-
cally active and potentially toxic. Most of phase 2 reactions take
place in cytosol and involve conjugation with endogenous com-
pounds via transferase enzymes. A group of enzymes located
in the endoplasmic reticulum, known as cytochrome P-450, is
themost important family of metabolizing enzymes in the liver.
Cytochrome P-450 is the terminal oxidase component of an elec-
tron transport chain. It is not a single enzyme, but rather
consists of a closely related family of 50 isoforms; six of them
metabolize 90% of drugs. There is a tremendous diversity of
individual P-450 gene products, and this heterogeneity allows
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the liver to perform oxidation on a vast array of chemicals (in-
cluding almost all drugs) in phase 1 (Lynch and Price, 2007).
2.4. Mechanism of liver damage
Drugs continue to be taken off the market due to late discov-
ery of hepatotoxicity. Due to its unique metabolism and close
relationship with the gastrointestinal tract, the liver is sus-
ceptible to injury from drugs and other substances. Seventy
five percent of blood coming to the liver arrives directly from
gastrointestinal organs and then spleen via portal veins that
bring drugs and xenobiotics in near-undiluted form. Several
mechanisms are responsible for either inducing hepatic injury
or worsening the damage process. Many chemicals damage mi-
tochondria, an intracellular organelle that produces energy. Its
dysfunction releases excessive amount of oxidants that, in turn,
injure hepatic cells (Fig. 2). Activation of some enzymes in the
cytochrome P-450 system such as CYP2E1 also leads to oxi-
dative stress, which in turn has a crucial role in liver damage.
Injury to hepatocyte and bile duct cells leads to accumula-
tion of bile acid inside the liver. This promotes further live
damage (Jaeschke et al., 2002).
2.5. Patterns of injury
Chemicals produce a wide variety of clinical and pathologi-
cal hepatic injury. Biochemical markers (e.g. alanine transferase,
alkaline phosphatase and bilirubin) are often used to
indicate liver damage. Liver injury is defined as a rise in either
(a) ALT level more than three times of the upper limit of normal
(ULN), (b) alkaline phospatase (ALP) level more than twice ULN,
or (c) total bilirubin level more than twice ULN when associ-
ated with increased ALT or ALP (Mumoli et al., 2006). Liver
damage is further characterized into hepatocellular (predomi-
nantly initial alanine transferase elevation) and cholestatic
(initial alkaline phosphatase rise) types. However, they are not
mutually exclusive and mixed types of injuries are often en-
countered.The liver synthesizes, concentrates, and secretes bile
acids and excretes other toxicants, such as bilirubin. Drug-
induced injury to hepatocytes and bile duct cells can lead to
cholestasis. Cholestasis, in turn, causes intrahepatic accumu-
lation of toxic bile acids and excretion products,which promotes
further hepatic injury (Jaeschke et al., 2002).
Marker enzymes are widely used to assess liver damage;
hence, we determined the levels of enzymes such as ALP, AST
and ALT. Necrosis or membrane damage releases the enzyme
into circulation; hence, it can be measured in the serum. High
levels of AST indicate liver damage, such as that caused by viral
hepatitis as well as cardiac infarction and muscle injury; AST
catalyzes the conversion of alanine to pyruvate and gluta-
mate and is released in a similar manner.Therefore,ALT is more
specific to the liver, and is thus a better parameter for detect-
ing liver injury. Elevated levels of serum enzymes are indicative
of cellular leakage and loss of functional integrity of cell mem-
brane in liver (Choudhary and Devi, 2014). SerumALP, bilirubin
and total protein levels, on the other hand, are related to the
Fig. 2 – Potential of antioxidants in preventing oxidation of biomolecules, DNA damage and degenerative diseases
(openi.nlm.nih.gov).
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function of hepatic cell. Increase in serum level of ALP is due
to increased synthesis, in the presence of increasing biliary pres-
sure (Muriel and Garcipiana, 1992). Increase in the level of these
serum enzymes ALP, acid phosphatase (ACP), AST, ALT, lactate
dehydrogenase (LDH) and gamma-glutamyl transferase (γ-
GT) was also observed. Lipid peroxidation leads to generation
of free radicals (such as peroxyl, alkoxyl and aldehyde) that
cause cell damage and leads to the release of marker enzymes.
Disruption of the ordered lipid-bilayer of the membrane struc-
ture is probably due to the presence of reactive oxygen species
produced due to oxidative stress, leading to the escape of de-
tectable quantity of these enzymes out of the cell into the
extracellular fluid.The reactive oxygen species might have oxi-
dized the polyunsaturated fatty acids which make up the lipid
bilayer resulting in its disruption.The elevated levels of serum
globulin also suggest adverse effect of reactive oxygen species
on the secretory ability of the liver, and hence it also affects
the normal functioning of the organ. Increased bilirubin pro-
duction, enhanced hepatic conjugation and biliary excretion
of the pigment present in aspartame-treated animals may be
a result of decreased uptake, conjugation or increased biliru-
bin production (Choudhary and Devi, 2014).
2.6. Chemicals and drug-induced hepatotoxicity
Aspartame is widely consumed by humans who are diabetic
and who are under weight loss regime. Aspartame (L-aspartyl-
L-phenylalanine methyl ester) also known as NutraSweet, after
oral administration to humans and experimental animals, is
rapidly and completely metabolized to 50% phenylalanine, 40%
aspartic acid and 10% methanol. Methanol is being increas-
ingly recognized as a substance that damages the liver cells,
where it is oxidized to formaldehyde and later to format
(Oppermann, 1984). These processes are accompanied by el-
evation of NADH level and the formation of superoxide anion,
which may be involved in lipid peroxidation (Parthasarathy
et al., 2006). Also, methanol intoxication is associated with mi-
tochondrial damage and increased microsomal proliferation,
resulting in increased production of oxygen radicals (Castro
et al., 2002). These factors together with the excess of form-
aldehyde formed during acute methanol intoxication cause
significant increase in lipid peroxidation (Parthasarathy et al.,
2006). Aspartame consumption in a long-term basis may affect
the brain and liver, and it may be due to its metabolite metha-
nol or aspartame may act as a chemical stressor to alter the
antioxidant status and histological pattern.Also, aspartame can
induce oxidative stress and hepatorenal toxicity. Long-term
treatment with aspartame may be responsible for oxidative
stress and hepatorenal toxicity (Ashok et al., 2013).
Carbon tetrachloride (CCl4) has been widely used for ex-
perimental induction of liver damage (Parola et al., 1992). The
principal causes of carbon tetrachloride (CCl4)-induced hepatic
damage are lipid peroxidation and decreased activities of an-
tioxidant enzymes and generation of free radicals (Poli, 1993).
Doxorubicin (DXR, trade name Adriamycin; also known as
hydroxy daunorubicin) has been widely used over the past
several decades to treat patients with various cancers, includ-
ing hepatocellular carcinoma, based on its ability to kill
transformed liver cells (Singal and Iliskovic, 2008). Liver damage
is a relatively common adverse effect in patients with other
cancers who are treated with DXR (Cainelli and Vallone, 2009).
DXR hepatotoxicity has been also reported in a number of
studies on animals (Ray et al., 2000; Ray and Mehendale, 2000;
Kalender et al., 2001; Ray, 2003). The mechanisms of DXR cy-
totoxicity in cancer cells include (i) intercalation into DNA with
inhibition of DNA replication and RNA transcription; (ii) gen-
eration of free radicals with DNA damage and lipid peroxidation;
(iii) DNA binding and arylation; (iv) DNA crosslinking; (v) in-
terference with DNA unwinding, DNA strand separation, and
helicase activity; (vi) direct membrane damage due to oxida-
tion of lipids; and (vii) inhibition of topoisomerase II (Zhang
et al., 2009).
Acetaminophen (APAP) is the most common non-steroidal
analgesic and antipyretic drug used worldwide.APAP exerts few
side effects in therapeutic doses, but hepatotoxicity is the fre-
quent consequence of APAP overdose (Olaleye et al., 2010). APAP
overdose is responsible for generation of a highly reactive me-
tabolite N-acetyl-p-benzoquinoneimine (NAPQI). NAPQI causes
covalent modification, reduction of enzyme activity, inhibi-
tion of protein oxidation, free radical generation, lipid
peroxidation, DNA fragmentation, mitochondrial dysfunc-
tion, alteration of innate immunity, deregulation of Ca2+
homeostasis, and depletion of glutathione, thus leading to hepa-
totoxicity (James et al., 2003).
2.7. Oxidative stress effect on hepatotoxicity
Oxidative stress reflects an imbalance between the systemic
manifestation of reactive oxygen species and a biological sys-
tem’s ability to readily detoxify the reactive intermediates or
to repair the resulting damage. Disturbances in the normal
redox state of cells can cause toxic effects through the pro-
duction of peroxides and free radicals that damage all
components of the cell, including proteins, lipids, and DNA.
Oxidative stress from oxidative metabolism causes base
damage, as well as strand breaks in DNA. Base damage is mostly
indirect and caused by the reactive oxygen species (ROS) gen-
erated, e.g. O2− (superoxide radical), OH (hydroxyl radical) and
H2O2 “hydrogen peroxide” (Chandra et al., 2015).
Oxidative stress affects the major cellular components:
proteins, lipids and DNA. The importance of oxidative stress
is commonly emphasized in the pathogenesis of various de-
generative diseases, such as diabetes, cancer, cardiovascular
disorders or neurodegenerative diseases (Apostolova et al.,
2011). Hence, the role of oxidant agents in cells is complex
and depends on the balance between oxidant and antioxi-
dant particles. Protective actions against ROS are performed
by several enzymes [(e.g., superoxide dismutase (SOD), cata-
lase and glutathione peroxidase)] as well as nonenzymatic
compounds (e.g., tocopherol, vitamin E, beta-carotene, ascor-
bate and glutathione (GSH)) (Mao et al., 2011). When the
capacity of this antioxidant system decreases, the level of
inactivated ROS rises. ROS generation also leads to altered
mitochondrial permeability and transition potential. These
changes induce the release of pro-apoptotic factors (e.g.,
cytochrome C) (Wang et al., 2013). Additionally, oxidative
stress may induce reversible and irreversible changes in
sensitive proteins. This process is often associated with
neurodegenerative disorders (Lu, 2008).
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2.8. The role of lipid peroxidation in hepatotoxicity
Lipid hydroperoxides are non-radical intermediates derived from
unsaturated fatty acids, phospholipids, glycolipids, choles-
terol esters and cholesterol itself. Their formation occurs in
enzymatic or non-enzymatic reactions involving activated
chemical species known as “reactive oxygen species” (ROS),
which are responsible for toxic effects in the body via various
tissue damages.These ROS include among others hydroxyl radi-
cals, lipid oxyl or peroxyl radicals, singlet oxygen, and
peroxynitrite formed from nitrogen oxide (NO), all these groups
of atoms behave as a unit and are now named “free radical.”
Lipid peroxidation leads to generation of free radicals (such as
peroxyl, alkoxyl and aldehyde), which cause cell damage and
lead to the release of marker enzymes.When liver and kidney
cell plasma membrane is damaged, a variety of enzymes nor-
mally located in the cytosol are released in to the blood stream.
Their estimation in the serum is a useful quantitative marker
of the extent and type of hepatic and renal cellular damage
(Pagana and Pagana, 2002).
3. Protective role of herbal plants
3.1. History
The study of herbs dates back over 5000 years to the Sumerians,
who described well-established medicinal uses for such plants
as laurel, caraway and thyme. Ancient Egyptian of 1000 B.C.
are known to have used garlic, opium, castor oil, coriander,mint,
indigo, and other herbs for medicine, and the old testament
also mentioned herb use and cultivation, including man-
drake, vetch, caraway, wheat, barley and rye. Also, the use of
herbal drugs can be traced back to 2100 B.C. in ancient China
at the time of Xia dynasty and in India during Vedic period.
The first written report dates back to 600 B.C. with the Charaka
Samhita of India and the early notes of Eastern Zhou dynasty
of China, which became systematized around 400 B.C.The age-
old system of herbal medicine is being revived by day-to-day
practice for its long-lasting curative effect, easy availability,
natural way of healing, and less side effects (Schuppan et al.,
1999).
3.2. Plants used as a medicine
Herbal medicines are gaining importance not only in India, but
all over the world. Alternate system of medicine in India uses
about 1200 plants for different ailments (Rai, 1994). Treat-
ment options for common liver diseases are limited and therapy
with modern medicine may lack in efficacy. The effective-
ness of treatments such as those using corticosteroids and
interferons is inconsistent, carries the risk of adverse events
and is often too costly (Stickel and Schuppan, 2007). So, there
is a need for effective therapeutic agents with a low inci-
dence of side effects. Plants potentially constitute such a group,
which is traditionally used as hepatoprotective agents (Luper,
1998).The easy accessibility without the need of laborious phar-
maceutical synthesis increased the attention toward the herbal
medicines (Stickel and Schuppan, 2007). Plant drugs are also
known to play a major role in the management of liver dis-
eases all over the world. There are many plants and herbal
extracts that have been shown to possess hepatoprotective ac-
tivities in Indian, Chinese, and Korean system of medicine
(Thyagarajan et al., 2002).
3.3. Plants biosynthesize a variety of phytochemicals
Phytochemicals are a large group of plant-derived com-
pounds hypothesized to be responsible for much of the disease
protection conferred from diets high in fruits, vegetables, beans,
cereals, and plant-based beverages such as tea and wine (Arts
and Hollman, 2005).
Phytochemicals include the following:
Alkaloids contain a ring with nitrogen. Many alkaloids have
dramatic effects on the central nervous system. Caffeine is
an alkaloid that provides a mild lift, but the alkaloids in
Datura cause severe intoxication.
Phenolic contains phenol ring. The anthocyanins that give
grapes their purple color, the isoflavones, the phytoestrogens
from soy, and the tannins that give tea its astringency are
phenolics (Table 1).
Terpenoids are built up from terpene building blocks. Each
terpene consists of two paired isoprenes. The names
monoterpenes, sesquiterpenes, diterpenes and triterpenes
are based on the number of isoprene units. The fragrance
of rose and lavender is due to monoterpenes. The carot-
enoids produce the reds, yellows and oranges of pumpkin,
corn and tomatoes.
Glycosides consist of glucose moiety attached to an agly-
cone.The aglycone is a molecule that is bioactive in its free
form but inert until the glycoside bond is broken by water
or enzymes.
The mechanism of hepatoprotection by these compounds
generally exerts multiple effects. Although they show
hepatoprotection due to antioxidant effect, there are other
effects like immunomodulatory, antiviral (Wiart et al., 2005) and
anti-inflammatory (Sandur et al., 2007).
The use of herbal resources for the treatment of liver dis-
eases is quite an old approach of various traditional systems
of medicine.These medicine systems conceptualize a general
imbalance of the dichotomous energies that leads to the disease
and they focus on medicine that balances these energies and
maintains good health.Mainly, herbs have been used for chronic
hepatitis C and alcohol-induced liver diseases. Phytomedicines
are traditionally used in the treatment of liver disorders and
are now included as complementary and alternative medi-
cine for liver patients. Several hundred plants have been
examined for use in a wide variety of liver disorders (Negi et al.,
2008).
3.3.1. Zingiber officinale (ginger)
Ginger (Zingiber officinale Roscoe, Zingiberaceae) (Fig. 3) is widely
used around the world in foods as a spice. For centuries, it has
been an important ingredient in Chinese, Ayurvedic and Tibb-
Unani herbal medicines for the treatment of catarrh,
rheumatism, nervous diseases, gingivitis, toothache, asthma,
stroke, constipation and diabetes (Awang, 1992; Tapsell et al.,
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2006; Wang and Wang, 2005). Among the pharmacological
effects demonstrated are anti-platelets, antioxidant, anti-
tumor, anti-rhino viral, anti-hepatotoxicity, anti-arthritic and
anti-inflammatory (Lantz et al., 2007). The antioxidant activ-
ity of gingerol and other constituents of ginger has been
confirmed (Aeschbach et al., 1994). Different doses of ginger
extract cause alterations in biochemical parameters, free radi-
cals, antioxidant enzymes and drug metabolizing enzymes
induced by bromobenzene in the liver of male rats and alle-
viating the toxicity of bromobenzene in the liver (El-Sharaky
et al., 2009). Curcumin, another active component present in
ginger, was found to be an antioxidant and anti-inflammatory
agent and induced haem oxygenase-1 and protected endo-
thelial cells against oxidative stress (Motterlini et al., 2000).The
antioxidants inhibit the reactive oxygen species (ROS), which
are capable of causing damage to DNA, associated with car-
cinogenesis, coronary heart disease, and many other health
problems related to advancing age (Patel et al., 2000). The
aqueous extract of ginger root may cause hepatoprotective
effect against aspartame, which may cause hepatotoxicity and
oxidative stress. Ginger root extract has hepatoprotective effect
against aspartame-induced hepatotoxicity and decreased liver
function markers (ALT, AST, ALP, γ-GT), serum total protein,
albumin and total bilirubin levels, serum LDH activity,
α-fetoprotein, and tumor necrosis factor (TNF), increased levels
of antioxidant enzymes, and reduced levels of malondialdehyde
(Hozayen and Abou Seif, 2014).
Table 1 – Examples of some flavonoids and their food sources (Lakhanpal and Rai, 2007).
Groups Compounds Food sources
Flavonols Quercetin
Kaempferol
Isorhamnetin
Quercetagetin
Yellow onion, curly kale, leek, cherry tomato, broccoli, apple, green and
black grapes, blueberry
Flavones Tangeretin
Heptamethoxyflavone
Nobiletin
Sinensetin
Quercetogetin
Chrysin
Luteolin
Disometin
Tricetin
Parsley, celery, Capsicum pepper
Flavanones Naringenin
Eriodictyol
Hesperetin
Dihydroquercetin
Dihydrofisetin
Dihydrobinetin
Orange juice, grapefruit juice, lemon juice
Flavanols Silibinin
Silymarin
Taxifolin
Pinobanksin
Coca, cocoa beverages, chocolates
Catechins (proanthocyanidins) (+) Catechin
Gallocatechin
(−) Epicatechin
Epigallocatechin
Epicatechin 3-gallate
Epigallocatechin 3-gallate
Chocolate, beans, apricot, cherry, grapes, peach, red wine, cider, green tea,
black tea, blackberry
Isoflavones Daidzein
Genistein
Glycitein
Soy, cheese, soy flour, soy bean, tofu
Anthocyanins Cyanidin
Delphinidin
Malvidin
Pelargonidin
Peonidin
Petunidin
Blueberry, blackcurrant, black grapes, cherry, rhubarb, plum, strawberry, red
wine, red cabbage
Fig. 3 – Zingiber officinale (http://www.alvita.com/herbal
-teas.html).
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3.3.2. Cucurbita pepo L. (pumpkin)
Pumpkin seeds (Cucurbita pepo L.) (Fig. 4) are a rich source of
unsaturated fatty acids, antioxidants and fibers, known to have
anti-atherogenic and hepatoprotective activities (Makni et al.,
2008). Pumpkin is one such plant that has been frequently used
as functional food or medicine (Caili et al., 2006). Some of its
common uses in most countries are for diabetes where it is
used internally as well as externally for management of worms
and parasites. Treatment of spontaneously hypertensive rats
with felodipine or captopril monotherapy or combined with
pumpkin seed oil produced improvement in the measured free
radical scavengers in the heart and kidney (Al-Zuhair et al.,
2000). Pumpkin is also rich in unsaturated fatty acids espe-
cially linoleic and oleic acid and tocopherols and with very high
oxidative stability (Stevenson et al., 2007). In addition to the
carotenoids and gamma aminobutyric acids (GABA) found in
the fruits (Liu et al., 2001), there are other biologically active
ingredients, which are found in pumpkins (Gossell-Williams
et al., 2008), such as sterols, proteins, peptides, polysaccha-
rides, para-aminobenzoic acid and fixed oils. Pumpkin seed oil’s
main nutrients are: essential fatty acid-omega 6, omega 9, phy-
tosterols, and antioxidants such as carotenoids, vitamin A and
vitamin E (Murkovic et al., 1996). Linoleic acid, a polyunsatu-
rated fatty acid present in pumpkin seed oil, is known to
increase membrane fluidity and allows for osmosis, intracel-
lular and extracellular gaseous exchange (Lovejoy, 2002).
Pumpkin seed oil includes fatty acids: palmitic (C 16:0), stearic
(C 18:0), oleic (C 18:1) and linoleic (C 18:2) (Kulaitiene et al., 2007).
Antioxidants are the substances that when present in low con-
centration significantly delay or reduce the oxidation of
the substrate (Halliwell, 2000). Pumpkin oil may play an
important role in the protection against alcohol-induced hepa-
totoxicity and oxidative stress. Pretreatment with pumpkin oil
may have hepatoprotective effects, which are varied and include
oxidation, anti-lipid peroxidation enhanced detoxification and
protection against glutathione depletion (Abou Seif, 2014a).
3.3.3. Citrus reticulata (mandarin)
The mandarin (Citrus reticulata), also known as the mandarine
(Fig. 5), is a small citrus tree with fruit resembling other oranges.
They are rich in vitamin C, flavonoids, acids and volatile oils.
Mandarin, as other citrus fruits, has nutritional importance due
to its particular composition. Flavonoids, especially polymethoxy
flavones and flavanones (hesperidin, rutin and naringin), are
identified in citrus pulp as well as in peel (Wang et al., 2008).
Rutin (quercetin rutinoside) is a glycoside of the flavonoid
quercetin. Rutin is used as a medication for blood vessel pro-
tection and is an ingredient of numerous multivitamin
preparations and herbal remedies. It can combine with cations,
supplying nutrients from the soil to the cells in plants (Luo et al.,
2008). In humans it is a potent antioxidant where its actions
include attaching to the iron ion (Fe2+), and preventing it from
binding to hydrogen peroxide, which would otherwise create
a highly reactive free-radical that may damage cells (Patel et al.,
Fig. 4 – Cucurbita pepo L (Various, 2013).
Fig. 5 – Citrus reticulate (Brown, 2002).
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2010). Rutin is the strongest antioxidant when compared with
quercetin, acacetin,morin, hispidulin, hesperidin, and naringin
(Chow et al., 2005), which are mostly isolated from citrus peel.
Hesperidin is a flavanone glycoside (flavonoid C28H34O15)
found abundantly in citrus fruits. Its aglycone form is called
hesperetin. Hesperidin is believed to play a role in plant defense.
It acts as an antioxidant according to in vitro studies. In human
nutrition, it contributes to the integrity of blood vessels (Farombi
et al., 2008). Hesperidin also has anti-inflammatory effects
(Emim et al., 1994). Dietary hesperidin exerts anti-carcinogenic
actions in the tongue, colon, esophagus, and urinary bladder
in rat carcinogenesis models (Tanaka et al., 2000). Hesperidin
has been reported to have many biological effects, including
anti-inflammatory, antimicrobial, anticarcinogenic, antioxi-
dant effects and decreasing capillary fragility (Garg et al., 2001).
Hesperidin, a flavonoid, has powerful protection effects on DNA
damage, reducing the frequency of micronuclei induced by
c-irradiation in mice (Hosseinimehr and Nemati, 2006). Hes-
peridin plays an important role in the protection against
doxorubicin-induced hepatotoxicity, by improving the activi-
ties of liver enzymes (ALT, AST, and ALP and GGT) in addition
to the amelioration in the levels of total bilirubin, albumin and
sialic acid. Rutin and hesperidin recorded a significant in-
crease in the liver glutathione level, glutathione peroxidase,
glutathione-S-transferase and peroxidase activities, and reduced
lipid peroxidation level. Pretreatment with rutin and hesperi-
din may protect the liver from the hepatotoxic effect caused
by doxorubicin (Hozayen et al., 2014).
3.3.4. Petroselinum crispum oil (parsley oil)
Parsley, Petroselinum crispum (Fig. 6), is a native herb of the central
Mediterranean region (southern Italy, Algeria, and Tunisia). It
is a part of the Apiaceae family and is a species of Petroselinum
(Lopez et al., 1999). The phenolic compounds of parsley were
responsible for its antibacterial and antioxidant activity (Wong
and Kitts, 2006). The antioxidant activity of this herb in terms
of B-carotene possesses bleaching capacity and free radical scav-
enging activity (Zhang et al., 2006). This concept was then
confirmed by further studies (Kolarovic et al., 2010). Parsley pos-
sesses several flavonoids such as apiin and luteolin, and its
essential oil contains apiol and myristicin. These compo-
nents are believed to be responsible for the therapeutic effects
of parsley (Mimica-Dukic and Popovic, 2007). Parsley oil plays
an important role by exerting an ameliorating effect on liver
function enzymes, antioxidation, anti-lipid peroxidation that
enhanced detoxification, and protection against glutathione
depletion against alcohol-induced hepatotoxicity and oxida-
tive stress (Abou Seif, 2014b).
3.3.5. Andrographis paniculata (king of bitters)
Andrographis paniculata (A. paniculata), known among the Indians,
is one of the most commonly used plants in the traditional
systems of Unani and Ayurvedic medicines. It is called Creat
in English and is known as the king of bitters (Jarukamjorn and
Nemoto, 2008).The aerial parts (Fig. 7) are most commonly used;
however, the whole plant or the roots are also used for certain
purposes in some manuscripts. A. paniculata has been re-
ported as having antibacterial (Leelarasamee et al., 1990), anti
malarial (Dua et al., 2004), antiviral (Wiart et al., 2005),
cardioprotective, antioxidant, anti-inflammatory (Sheeja et al.,
2006), antidiabetic effects and also antitumor activities (Zhao
et al., 2008).Treatment with whole plant extract of A. paniculata
effectively reduced the level of lipid peroxidation and in-
creased the status of antioxidant enzymes. This may be due
to the presence of various flavonoids, phenols and glycosides
in the drug (Subramaniam et al., 2015).
3.3.6. Silybum marianum (milk thistle)
Silymarin, derived from the seeds of Silybum marianum L.
(Family: Asteraceae or Compositae), is a member of sun-
flower family and commonly called milk thistle.The plant has
been used for centuries as a natural remedy for liver and biliary
tract diseases. The leaves are characterized by distinct white
“milky” veins that give the plant its common name.The active
constituents of thistle are flavonolignans, including silybin,
silydianin and silychristin, collectively known as silymarins
(Shaarawy et al., 2009). Silybin is the component with the great-
est degree of biologically active and milk thistle extracts are
usually standardized to contain 70–80 percent silybin. Silymarin
is found in the entire plant but is concentrated in the fruit
(Fig. 8) and seeds. Silybum seeds also contain betaine (a proven
hepatoprotector) and essential fatty acids, which may con-
tribute to silymarins’ anti-inflammatory effect (Saller et al.,
2001).
Silymarin has been reported to protect liver cells from awide
variety of toxins, including acetaminophen, ethanol, CCl4 and
D-galactosamine (Rasool et al., 2014). The mechanisms that
provide silymarins their hepatoprotective effects are many and
varied, and include anti-oxidation, anti-lipid peroxidation
enhanced detoxification and protection against glutathione
depletion (Pradhan and Girish, 2006).
Fig. 6 – Petroselinum crispum (www.edenbrothers.com).
Fig. 7 – Andrographis paniculata (Zell, 2009).
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3.3.7. Camellia sinensis (green tea)
Green tea leaves (Fig. 9) produce organic compounds that may
be involved in the defense of plants against invading patho-
gens, and these metabolites are known as polyphenols
(Friedman, 2007), which include catechin, epicatechin,
epigallocatechin, tannins and caffeine (Wang and Goodman,
1999). Green tea displays antioxidants and free radical scav-
enger properties (Crespy and Williamson, 2004). The green tea
extract and its main catechin polyphenols havemedicinal value
for the prevention of and therapeutics in several diseases
(Ostrowska and Skrzydlewska, 2006). The green tea exerts im-
provement in liver function by preventing the production of
reactive oxygen species (ROS) and enhancing the antioxidant
defense system capacity. Thus green tea extract has protec-
tive effects against ethanol toxicity (Lodhi et al., 2014).
3.4. Drugs derived from herbal plants
Many drugs are derived from plants. Some examples of drugs
that consist of plant ingredients are shown in Table 2 and
include the following:
a. Lovenox: The active principles: curcumin 2%, silymarin 80%
and dandelion extract (Taraxacum officinale). It improves liver
functions.
b. Hepanox capsules: It contains silymarin and vitamins A,
C and E. It is hepatoprotective and antioxidant.
c. Legalon: The main active principle is silymarin, which im-
proves liver function and protects against liver damage.
d. Lipocholine tablets: lipotropic agent: The active constitu-
ents are extract of artichoke (Cynara scolymus) and a group
of vitamin B.
4. Summary and conclusion
The liver is the largest, important organ and the site for es-
sential biochemical reactions in the human body. It has the
function to detoxify toxic substances and synthesize useful
biomolecules.Therefore, damage to the liver leads to grave con-
sequences.This damage resulted from chronic alcoholic abuse,
viral hepatitis or inherited metabolic disease. Liver damage is
associated with cellular necrosis, fibrosis, and increase in tissue
lipid peroxidation and depletion in tissue glutathione level.Most
of the hepatotoxic chemicals damage liver cells mainly by in-
ducing lipid peroxidation and other oxidative damages.
Natural antioxidants are found in many compounds clas-
sified as secondary plant metabolites, e.g. polyphenols (phenolic
acids and flavonoids) and terpenoids (carotenoids), and the con-
sumption of foods that contain these compounds in large
quantities seems to play an important role in prophylaxis
against many diseases.
Herbal medicines derived from plant extracts are being in-
creasingly utilized to treat a wide variety of clinical disease.
More attention has been paid to the protective effects of natural
antioxidants against drug-induced toxicities especially when-
ever free radical generation is involved. Popularity of herbal
remedies is increasing and at least one quarter of patients with
liver disease use botanicals. The World Health Organization
(WHO) estimates that 80 percent of the population of some
Asian and African countries presently use herbal medicine for
some aspects of primary health care. Some medicinal herbs
have proven hepatoprotective potential. Silybummarianum (milk
thistle) has been used to treat liver diseases since the 16th
century. Its major constituents are the flavonoids silibinin,
silydianin, silychristin, and isosilibinin, of which silibinin is the
biologically most active compound and used for standardiza-
tion of pharmaceutical products.
Fig. 8 – Silybum marianum (www.amazon.com).
Fig. 9 – Camellia sinensis (www.camelliasrus.com.au).
Table 2 – Drugs derived from herbal plants.
Lovenox Hepanox capsules Legalon Lipocholine tablets
www.suggestkeyword.com
www.thevits.com goldpharma.com
www.solgaronline.co.uk
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4.1. Egyptian experience
Medicinal plants have been used as a source of remedies since
ancient times in Egypt. Egyptian experience was previously
mentioned inside the literature (underlined authors), such as
Al-Zuhair et al. (2000), Abdel-Salam et al. (2014), Abou Seif
(2014a,b), Hozayen and Abou Seif (2014, 2015), Hozayen et al.
(2014), and Shaarawy et al. (2009).
5. Recommendation
Popularity of herbal remedies is increasing and at least one
quarter of patients with liver disease use botanicals.
• Further collaboration between researchers in the fields of
biology, pharmacognosy and medicinal sciences is re-
quired to elucidate the biological activity of the medicinal
herbs’ constituents and to assess their efficacy and safety
in human beings and approval by the Food and Drug Ad-
ministration (FDA).
• Egypt has a great role to play, as supplier of herbal prod-
ucts, not only to meet the domestic needs, but also to take
advantage of the tremendous export potential.
• In Egypt, all herbal ingredients must be classified accord-
ing to their botanical names beside their popular/common
(commercial) names.
• Focusing on such phytochemicals and its cytotoxic mecha-
nism might be valuable in determining the role of these
chemicals in normal and altered body physiology.
• Daily foods must contain vegetables and fruits, which have
polyphenolic compounds and vitamins that help to restore
the balance between the antioxidants and free radicals and
enhance body defense against diseases.
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